Amber B. Clemmons

483 total citations
38 papers, 326 citations indexed

About

Amber B. Clemmons is a scholar working on Oncology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Amber B. Clemmons has authored 38 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Hematology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Amber B. Clemmons's work include Neutropenia and Cancer Infections (8 papers), Acute Lymphoblastic Leukemia research (6 papers) and Nausea and vomiting management (4 papers). Amber B. Clemmons is often cited by papers focused on Neutropenia and Cancer Infections (8 papers), Acute Lymphoblastic Leukemia research (6 papers) and Nausea and vomiting management (4 papers). Amber B. Clemmons collaborates with scholars based in United States, Georgia and Denmark. Amber B. Clemmons's co-authors include David L. DeRemer, Stephen M. Clark, Andrea Clarke, Claude Sportès, Vamsi Kota, LeAnne Kennedy, Maurice Alexander, Jeremy Pantin, Imran Ahmad and Christopher M. Bland and has published in prestigious journals such as SHILAP Revista de lepidopterología, Supportive Care in Cancer and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

Amber B. Clemmons

36 papers receiving 319 citations

Peers

Amber B. Clemmons

ONCOL

HEMAT

PHEOH

SURGE

Maïté Jaureguy France

İbrahim Bayram Türkiye

Jennifer E. Schwartz United States

Zegeye Getaneh Ethiopia

Donald Harvey United States

Beth A. Kurt United States

A. Galera Spain

Omri Cohen Israel

Yachana Kataria United States

Marko Kavčič United States

Maïté Jaureguy France

Amber B. Clemmons

68 ×0.7

ONCOL

78 ×1.1

HEMAT

35 ×0.6

PHEOH

70 ×1.3

SURGE

50 ×1.3

Citations per year, relative to Amber B. Clemmons Amber B. Clemmons (= 1×) peers Maïté Jaureguy

Countries citing papers authored by Amber B. Clemmons

Since Specialization

Citations

This map shows the geographic impact of Amber B. Clemmons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber B. Clemmons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber B. Clemmons more than expected).

Fields of papers citing papers by Amber B. Clemmons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amber B. Clemmons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber B. Clemmons. The network helps show where Amber B. Clemmons may publish in the future.

Co-authorship network of co-authors of Amber B. Clemmons

This figure shows the co-authorship network connecting the top 25 collaborators of Amber B. Clemmons. A scholar is included among the top collaborators of Amber B. Clemmons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amber B. Clemmons. Amber B. Clemmons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sadek, Ramses, et al.. (2024). Assessing Outcomes in Patients With Multiple Myeloma Postautologous Stem Cell Transplantation: Contrasting the Effects of Melphalan Dosages at 200 mg/m2 versus 140 mg/m2. Clinical Lymphoma Myeloma & Leukemia. 24(9). 642–647. 1 indexed citations

Hawkins, W. Anthony, Andrea Sikora, Beth Bryles Phillips, et al.. (2023). Translating Clinical Decision-Making Skills From a Critical Care Pharmacy Elective to the Required Curriculum. American Journal of Pharmaceutical Education. 88(1). 100599–100599. 2 indexed citations

Clarke, Andrea, et al.. (2022). Belantamab Mafodotin-blmf: A Novel Antibody-Drug Conjugate for Treatment of Patients With Relapsed/Refractory Multiple Myeloma. Journal of the Advanced Practitioner in Oncology. 13(1). 77–85. 17 indexed citations

Hawkins, W. Anthony, et al.. (2021). Fluid Stewardship of Maintenance Intravenous Fluids. Journal of Pharmacy Practice. 35(5). 769–782. 15 indexed citations

Clemmons, Amber B., et al.. (2021). Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremia. Diagnostic Microbiology and Infectious Disease. 101(2). 115444–115444. 11 indexed citations

Clemmons, Amber B., et al.. (2021). Premedications for Cancer Therapies: A Primer for the Hematology/Oncology Provider. Journal of the Advanced Practitioner in Oncology. 12(8). 810–832. 5 indexed citations

Clemmons, Amber B., et al.. (2020). Assessing the impact of adding acetazolamide to oral or intravenous sodium bicarbonate as compared with intravenous bicarbonate monotherapy as urinary alkalinization in adults receiving high-dose methotrexate. Supportive Care in Cancer. 29(3). 1527–1534. 5 indexed citations

Clemmons, Amber B., et al.. (2020). Outcomes for Patients Receiving Ibrutinib with or without Antifungal Therapy. 1 indexed citations

DeRemer, David L., et al.. (2019). Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors. Journal of Oncology Pharmacy Practice. 26(3). 647–654. 17 indexed citations

10.

Clemmons, Amber B., et al.. (2019). Letermovir for Cytomegalovirus Prevention in Patients Undergoing Hematopoietic Cell Transplantation. Journal of the Advanced Practitioner in Oncology. 10(7). 730–735.

11.

Waller, Jennifer L., et al.. (2018). Prolonged versus short infusion rates for intravenous magnesium sulfate administration in hematopoietic cell transplant patients. Supportive Care in Cancer. 26(8). 2809–2814. 1 indexed citations

12.

Clemmons, Amber B., et al.. (2018). Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O Trial. Biology of Blood and Marrow Transplantation. 24(10). 2065–2071. 32 indexed citations

13.

Clemmons, Amber B., et al.. (2017). The Hematopoietic Cell Transplant Pharmacist: Roles, Responsibilities, and Recommendations from the ASBMT Pharmacy Special Interest Group. Biology of Blood and Marrow Transplantation. 24(5). 914–922. 25 indexed citations

14.

Clemmons, Amber B., et al.. (2017). Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime. Biology of Blood and Marrow Transplantation. 24(4). 820–826. 19 indexed citations

15.

Clark, Stephen M., et al.. (2016). Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center. Annals of Pharmacotherapy. 50(7). 541–547. 16 indexed citations

16.

Mangaonkar, Abhishek A., Hongyan Xu, Mohsin Jamal, et al.. (2016). Prognostic value of complete remission with superior platelet counts in acute myeloid leukemia. The Journal of Community and Supportive Oncology. 14(2). 66–71. 3 indexed citations

17.

Clemmons, Amber B., et al.. (2015). Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Chronic Lymphocytic Leukemia. Journal of the Advanced Practitioner in Oncology. 6(4). 370–4. 19 indexed citations

18.

Clark, Stephen M., et al.. (2015). Fosaprepitant for the prevention of nausea and vomiting in patients receiving BEAM or high-dose melphalan before autologous hematopoietic stem cell transplant. Journal of Oncology Pharmacy Practice. 22(3). 416–422. 3 indexed citations

19.

Clark, Stephen M., et al.. (2014). Pomalidomide for the Treatment of Multiple Myeloma. Journal of the Advanced Practitioner in Oncology. 5(1). 51–6. 6 indexed citations

20.

Kota, Vamsi, et al.. (2014). Congestive heart failure during induction with anthracycline-based therapy in patients with acute promyelocytic leukemia. The Journal of Community and Supportive Oncology. 12(11). 390–393. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact